BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7980430)

  • 1. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
    Stenstad T; Magnus JH; Husby G
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brefeldin A inhibits experimentally induced AA amyloidosis.
    Stenstad T; Husby G
    J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
    Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
    Ailles L; Kisilevsky R; Young ID
    Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
    Snow AD; Bramson R; Mar H; Wight TN; Kisilevsky R
    J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and partial characterization of heparan sulphate proteoglycans from human hepatic amyloid.
    Magnus JH; Stenstad T; Husby G; Kolset SO
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):225-31. PubMed ID: 1445267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High molecular weight glycosaminoglycans in AA type amyloid fibril extracts from human liver.
    Magnus JH; Kolset SO; Husby G
    Ann Rheum Dis; 1991 Aug; 50(8):562-6. PubMed ID: 1888198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.
    Wien TN; Sørby R; Omtvedt LA; Landsverk T; Husby G
    Scand J Immunol; 2004 Dec; 60(6):600-8. PubMed ID: 15584971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of glycosaminoglycans in human renal and splenic secondary AA amyloid fibril preparations.
    Stenstad T; Magnus JH; Kolset SO; Husby G
    Scand J Rheumatol; 1991; 20(1):1-7. PubMed ID: 2011711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils.
    Snow AD; Willmer J; Kisilevsky R
    Lab Invest; 1987 Dec; 57(6):687-98. PubMed ID: 2447384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of proteoglycans and glycosaminoglycans in bovine renal AA-type amyloidosis.
    Niewold TA; Flores Landeira JM; van den Heuvel LP; Ultee A; Tooten PC; Veerkamp JH
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):321-8. PubMed ID: 1685039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macromolecular properties of glycosaminoglycans in primary AL amyloid fibril extracts of lymphoid tissue origin.
    Stenstad T; Magnus JH; Kolset SO; Cornwell GG; Husby G
    Scand J Immunol; 1991 Nov; 34(5):611-7. PubMed ID: 1947796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins.
    Rada JA; Cornuet PK; Hassell JR
    Exp Eye Res; 1993 Jun; 56(6):635-48. PubMed ID: 8595806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation from SAA2-fibrils to AA-fibrils in amyloid fibrillogenesis: in vivo observations in murine spleen using anti-SAA and anti-AA antibodies.
    Arai K; Miura K; Baba S; Shirasawa H
    J Pathol; 1994 Jun; 173(2):127-34. PubMed ID: 8089807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of proteoglycans and glycosaminoglycans in splenic AA amyloid induced in mink.
    Wien TN; Omtvedt LA; Landsverk T; Husby G
    Scand J Immunol; 2000 Dec; 52(6):576-83. PubMed ID: 11119263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of haem oxygenase in AA amyloidogenesis.
    Kuroiwa M; Aoki K; Izumiyama N
    J Electron Microsc (Tokyo); 2004; 53(4):417-22. PubMed ID: 15582941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high resolution ultrastructural study of experimental murine AA amyloid.
    Inoue S; Kisilevsky R
    Lab Invest; 1996 Mar; 74(3):670-83. PubMed ID: 8600318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of amyloid-associated heparan sulphate proteoglycans and galactosaminoglycan free chains from human tissues.
    Stenstad T; Magnus JH; Husby G; Kolset SO
    Scand J Immunol; 1993 Feb; 37(2):227-35. PubMed ID: 8434233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inventory of human skin fibroblast proteoglycans. Identification of multiple heparan and chondroitin/dermatan sulphate proteoglycans.
    Schmidtchen A; Carlstedt I; Malmström A; Fransson LA
    Biochem J; 1990 Jan; 265(1):289-300. PubMed ID: 2137331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological study of experimental murine AA amyloidosis.
    Kuroiwa M; Aoki K; Izumiyama N
    J Electron Microsc (Tokyo); 2003; 52(4):407-13. PubMed ID: 14599103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.